Neuland Labs. Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Gross Sales	1191.20	951.08	936.91	762.71	666.83
Excise Duty	--	--	--	--	--
Net Sales	1191.20	951.08	936.91	762.71	666.83
Other Operating Income	--	--	--	--	--
Other Income	9.75	2.08	16.10	3.89	3.49
Total Income	1200.95	953.15	953.01	766.60	670.32
Total Expenditure	919.36	808.46	790.09	660.82	608.46
PBIDT	281.59	144.70	162.91	105.78	61.86
Interest	13.07	13.50	17.90	21.57	15.66
PBDT	268.52	131.20	145.02	84.20	46.20
Depreciation	52.78	49.04	39.68	31.28	25.86
Minority Interest Before NP	--	--	--	--	--
Tax	50.44	20.43	12.56	0.10	5.57
Deferred Tax	1.79	(2.09)	12.15	36.62	(1.67)
Reported Profit After Tax	163.52	63.82	80.63	16.21	16.44
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	163.52	63.82	80.63	16.21	16.44
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	163.52	63.82	80.63	16.21	16.44
EPS (Unit Curr.)	127.45	49.74	62.85	12.63	13.06
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	100	50	50	20	--
Equity	12.90	12.90	12.90	12.90	12.90
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	23.64	15.21	17.39	13.87	9.28
PBDTM(%)	22.54	13.79	15.48	11.04	6.93
PATM(%)	13.73	6.71	8.61	2.13	2.46

QuickLinks for Neuland Laboratories Ltd.